title: Patient-Centered Communication for Discussing Oncotype DX Testing.
abstract: Oncotype DX testing (ODX), a tumor gene expression test, may improve breast cancer care, however, communicating results remains challenging. We identified patient-centered communication strategies/gaps for discussing ODX results. We applied a patient-centered communication framework to analyze qualitative interviews with oncologists about how they communicate about ODX with patients, using template analysis in Atlas.ti. Overall, providers discussed four patient-centered communication domains: exchanging information, assessing uncertainty, making decisions and cross-cutting themes. Providers did not report discussing emotional aspects of managing uncertainty, assessing decision-making preferences, and evaluating decisions. A patient-centered approach may be a model for communicating about tumor gene expression tests.
authors.affiliation: a Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.|b Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Megan C
authors.initials: MC
authors.lastname: Roberts
authors.affiliation: c Department of Health Behavior , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Bryson
authors.affiliation: a Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.|d Center for Health Services Research, Durham Veterans Affairs Medical Center , Durham , NC , USA.
authors.forename: Morris
authors.initials: M
authors.lastname: Weinberger
authors.affiliation: a Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.|b Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.|e Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Stacie B
authors.initials: SB
authors.lastname: Dusetzina
authors.affiliation: f Duke Clinical Research Institute, Duke University , Durham , NC , USA.|g Duke Cancer Institute, Duke University , Durham , NC , USA.
authors.forename: Michaela A
authors.initials: MA
authors.lastname: Dinan
authors.affiliation: b Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Katherine E
authors.initials: KE
authors.lastname: Reeder-Hayes
authors.affiliation: a Department of Health Policy and Management , University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.|b Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill , Chapel Hill , NC , USA.
authors.forename: Stephanie B
authors.initials: SB
authors.lastname: Wheeler
mesh_terms: D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics* / Q000628:therapy; D000066491:Clinical Decision-Making; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D005820:Genetic Testing / Q000379:methods; D019538:Health Care Surveys; D058015:Health Communication; D006801:Humans; D008297:Male; D009657:North Carolina; D000072103:Oncologists; D018802:Patient-Centered Care / Q000379:methods; D057285:Precision Medicine / Q000379:methods; D012680:Sensitivity and Specificity; D035501:Uncertainty
chemical_list: D014408:Biomarkers, Tumor
keywords: Breast cancer; Communication; Patient-centered communication; Qualitative methods; Tumor gene profiling